메뉴 건너뛰기




Volumn 14, Issue 7 SUPPL. 4, 2000, Pages 26-30

Gemcitabine/carboplatin combination regimens: Importance of dose schedule

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; DEOXYCYTIDINE; DRUG DERIVATIVE; GEMCITABINE;

EID: 0034221095     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (10)

References (5)
  • 1
    • 0028843552 scopus 로고
    • Chemotherapy in non-small-cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomized clinical trials
    • Non-Small-Cell Lung Cancer Collaborative Group: Chemotherapy in non-small-cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomized clinical trials. Br Med J 311:899-909, 1995.
    • (1995) Br Med J , vol.311 , pp. 899-909
  • 2
    • 0023922084 scopus 로고
    • Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer: Report of a Canadian multicenter randomized trial
    • Rapp E, Pater JL, Willan A, et al: Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer: Report of a Canadian Multicenter Randomized Trial. J Clin Oncol 6:633-641, 1988.
    • (1988) J Clin Oncol , vol.6 , pp. 633-641
    • Rapp, E.1    Pater, J.L.2    Willan, A.3
  • 3
    • 0032887573 scopus 로고    scopus 로고
    • Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: Effects on survival and quality of life
    • Cullen MH, Billingham LJ, Woodroffe CM, et al: Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: Effects on survival and quality of life. J Clin Oncol 17(10):3188-3194, 1999.
    • (1999) J Clin Oncol , vol.17 , Issue.10 , pp. 3188-3194
    • Cullen, M.H.1    Billingham, L.J.2    Woodroffe, C.M.3
  • 4
    • 0025826624 scopus 로고
    • Survival determinants in extensive-stage non-small-cell lung cancer: The southwest oncology group experience
    • Albain KS, Crowley JJ, LeBlanc M, et al: Survival determinants in extensive-stage non-small-cell lung cancer: The Southwest Oncology Group experience. J Clin Oncol 9:1618-1626, 1991.
    • (1991) J Clin Oncol , vol.9 , pp. 1618-1626
    • Albain, K.S.1    Crowley, J.J.2    LeBlanc, M.3
  • 5
    • 0030020182 scopus 로고    scopus 로고
    • Promising new agents in the treatment of non-small cell lung cancer
    • Edelman MJ, Gandara DR: Promising new agents in the treatment of non-small cell lung cancer. Cancer Chemother Pharmacol 37:385-393, 1996.
    • (1996) Cancer Chemother Pharmacol , vol.37 , pp. 385-393
    • Edelman, M.J.1    Gandara, D.R.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.